National Assembly gives final approval to assisted-dying bill after years of debate


The French National Assembly is draped with the artwork “Marianne rêve” (“Marianne Dreams”) [AP Photo]
France’s National Assembly gave final approval Wednesday to a bill allowing adults with incurable illnesses to receive lethal medication, the culmination of years of debate over end-of-life care.
But the 291-241 vote in the lower house of parliament doesn’t mean the bill immediately becomes law. There will be a review to determine if it complies with the French Constitution.
The National Assembly approved the measure after backing it in three previous readings. French President Emmanuel Macron announced the legislation more than three years ago.
“In 2022, I committed to opening this path with the French people,” Macron said in a message posted on X. “With seriousness, with humility, and with full respect for our democracy, that commitment has been fulfilled.”
According to various estimates, assisted dying is available to around 300 million people worldwide, with euthanasia legal under certain conditions in some countries and assisted suicideallowed in others and in several U.S. states. France has an increasingly aging population, with growing numbers of patients in the country who require care for chronic illnesses.
France, a traditionally Catholic nation, has grappled with legal, medical, moral and religious questions about end-of-life options, including existing legislation that allows doctors to keep terminally ill patients sedated before death, but stops short of allowing assisted suicide and euthanasia.
“The national representation has risen to the occasion during these debates. This has been the longest debate since the 1980s,” said Yael Braun-Pivet, the president of the National Assembly.
Many French people have traveled to neighboring countries where medically assisted suicide or euthanasia are legal. Medically assisted suicide generally involves a patient voluntarily taking lethal medication prescribed by a doctor. Euthanasia involves a doctor or other healthcare professional administering a lethal injection at the patient’s request.
End-of-life options are also being debated in the United Kingdom. A bill to legalize assisted dying in England and Wales will formally return to Parliament on Sept. 11, five months after it ran out of time in Parliament’s last session.
The bill sets strict conditions
The proposed measure in France primarily provides for medically assisted suicide, by allowing patients to receive and self-administer lethal medication under strict conditions. Only people whose physical condition prevents them from doing so would be allowed to receive assistance from a doctor or a nurse.
Patients seeking to end their lives would have to be at least 18 years old and either French citizens or legal residents of France.
A doctor would first have to consult a team of healthcare professionals and then confirm that the patient has a serious and incurable illness that is life-threatening. The patient must be in an advanced or terminal stage, experiencing pain that can’t be relieved or is unbearable, and seeking lethal medication of their own free will.
Lawmakers specified that psychological suffering alone wouldn’t qualify a person for medically assisted dying.
People with severe psychiatric disorders or neurodegenerative diseases such as Alzheimer’s wouldn’t be eligible.
Patients would initiate the request, to be reviewed by health professionals within 15 days, and then confirm it after a period of reflection lasting at least two days.
If approved, they could take the lethal medication at the time and in the place of their choice, including at home or in a healthcare facility, in the presence of their loved ones if they wish.
On the chosen date, the doctor or nurse would have to verify that the person still wishes to proceed and remain nearby to intervene if complications arise.
France’s national health insurance system would cover all associated costs. SYLVIE CORBET & SAMUEL PETREQUIN, PARIS, MDT/AP
Leave a reply
You must be logged in to post a comment.

























